Topics
Pediatric CNS tumors | Treatment | Targeted therapy | Erdafitnib
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Targeted therapy > Erdafitnib
Stepien N, Mayr L, Schmook MT,
Raimann A, Dorfer C, Peyrl A, Azizi AA, Schramm K, Haberler C,
Gojo J.
Feasibility
and antitumour activity of the FGFR inhibitor erdafitnib in three
paediatric CNS tumour patients.
Pediatr
Blood Cancer.
2024 Jan 4:e30836. doi:
10.1002/pbc.30836. PMID:
38177074. Case report. ˍ